Doximity, Inc. DOCS
We take great care to ensure that the data presented and summarized in this overview for Doximity, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DOCS
View all-
Vanguard Group Inc Valley Forge, PA11.2MShares$596 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.8MShares$573 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL6.23MShares$331 Million0.87% of portfolio
-
Clearbridge Investments, LLC New York, NY5.12MShares$273 Million0.23% of portfolio
-
Baillie Gifford & CO4.94MShares$263 Million0.21% of portfolio
-
State Street Corp Boston, MA3.89MShares$207 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.08MShares$164 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$157 Million0.01% of portfolio
-
Durable Capital Partners LP Bethesda, MD2.89MShares$154 Million1.34% of portfolio
-
Loomis Sayles & CO L P2.33MShares$124 Million0.16% of portfolio
Latest Institutional Activity in DOCS
Top Purchases
Top Sells
About DOCS
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Insider Transactions at DOCS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2025
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
7,000
-15.43%
|
$399,000
$57.97 P/Share
|
|
Apr 01
2025
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
7,000
+22.86%
|
-
|
|
Mar 03
2025
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,000
-10.74%
|
$140,000
$70.89 P/Share
|
|
Mar 03
2025
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,000
+9.7%
|
-
|
|
Feb 15
2025
|
Jeffrey Tangney Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,474
-0.4%
|
$652,498
$77.07 P/Share
|
|
Feb 15
2025
|
Anna Bryson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,121
-1.55%
|
$394,317
$77.07 P/Share
|
|
Feb 12
2025
|
Kevin Spain |
SELL
Other acquisition or disposition
|
Indirect |
2,604,023
-66.67%
|
-
|
|
Feb 12
2025
|
Kevin Spain |
BUY
Conversion of derivative security
|
Indirect |
2,410,273
+50.0%
|
-
|
|
Feb 12
2025
|
Jeffrey Tangney Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
775,557
-7.25%
|
$58,166,775
$75.34 P/Share
|
|
Feb 12
2025
|
Jeffrey Tangney Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
200,000
-100.0%
|
-
|
|
Feb 12
2025
|
Watkin Phoebe L. Yang Director |
SELL
Open market or private sale
|
Direct |
2,889
-16.4%
|
$216,675
$75.19 P/Share
|
|
Feb 11
2025
|
Jeffrey Tangney Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-5.36%
|
$3,850,000
$77.39 P/Share
|
|
Feb 11
2025
|
Jeffrey Tangney Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
178,334
-2.93%
|
$13,553,384
$76.02 P/Share
|
|
Feb 11
2025
|
Jeffrey Tangney Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
178,334
+5.51%
|
-
|
|
Feb 11
2025
|
Anna Bryson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
95,000
-4.79%
|
$7,315,000
$77.11 P/Share
|
|
Feb 11
2025
|
Anna Bryson Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
95,000
+18.29%
|
-
|
|
Feb 11
2025
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.78%
|
$154,000
$77.81 P/Share
|
|
Feb 11
2025
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,000
+9.7%
|
-
|
|
Feb 11
2025
|
Regina M. Benjamin Director |
SELL
Open market or private sale
|
Direct |
40,000
-20.26%
|
$3,080,000
$77.12 P/Share
|
|
Feb 11
2025
|
Regina M. Benjamin Director |
BUY
Conversion of derivative security
|
Direct |
40,000
+41.4%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 284K shares |
|---|---|
| Conversion of derivative security | 11.4M shares |
| Open market or private sale | 1.45M shares |
|---|---|
| Other acquisition or disposition | 10.5M shares |
| Payment of exercise price or tax liability | 51K shares |
| Bona fide gift | 200K shares |